Results 1 to 10 of about 31,703 (224)

Anti-CD38 Therapy With Daratumumab in High-Risk IgA Nephropathy. [PDF]

Kidney Int Rep
Poux M, De Vriese AS, Cohen C, Duong Van Huyen JP, Daugas E, Jolivot A, Joher N, Matignon M, Hertig A, El Karoui K.   +9 more
europepmc   +1 more source

IgA Nephropathy: Mechanisms, Risk Stratification, and Precision Therapy. [PDF]

Diagnostics (Basel)
Alobaidi S.
europepmc   +1 more source

Quantifying Podocyte Depletion and Loss in IgA Nephropathy: A Dual Tissue and Urine Podometric Approach. [PDF]

Kidney360
Haruhara K, Yokoo T.
europepmc   +1 more source

Recurrence of IgA nephropathy in a kidney transplant patient successfully treated with iptacopan-a case report. [PDF]

Front Immunol
Pandav J, Kummangal B, Smith J, De Mattos A, Stack M, Ahmad Z, Andeen N, Kung V, Olyaei A, Rehman S.   +9 more
europepmc   +1 more source

A mixed presentation of IgA nephropathy and malignant hypertension with histological thrombotic Microangiopathy. [PDF]

Oxf Med Case Reports
Isaacs M, Talukdar UK, Gokula K, Mutatiri C.   +3 more
europepmc   +1 more source

Total Nephron Number: A Novel Predictor of Disease Progression in IgA Nephropathy. [PDF]

Kidney360
Miyasato Y, Yokoi H.
europepmc   +1 more source

IgA Nephropathy in a Patient with Tularemia: Causality or Coincidental Association? [PDF]

Infect Dis Clin Microbiol
Çakır Kıymaz Y, Keskin E, Kaya Ş, Candan F.   +3 more
europepmc   +1 more source

A Case Study and Review of the Literature on IgA Nephropathy in Crohn's Disease. [PDF]

Clin Case Rep
Vazzana GF, Romano A, Casuscelli C, La Spada A, Santoro D, Chimenz R, Romano C.   +6 more
europepmc   +1 more source

Refractory Status Epilepticus as an Initial Manifestation of IgA Nephropathy. [PDF]

J Clin Neurol
Kwack DW, Hwang H, Park JY, Kim DW.
europepmc   +1 more source